376 related articles for article (PubMed ID: 22419022)
1. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
3. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
[TBL] [Abstract][Full Text] [Related]
5. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
6. Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer.
Yang X; Liu Y; Mani H; Olson J; Clawson G; Caruso C; Bruggeman R; Varlotto JM; Zander DS; Rassaei N
Pathol Oncol Res; 2017 Jan; 23(1):73-77. PubMed ID: 27411924
[TBL] [Abstract][Full Text] [Related]
7. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y
Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957
[TBL] [Abstract][Full Text] [Related]
9. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
[TBL] [Abstract][Full Text] [Related]
12. Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.
Ren S; Su C; Wang Z; Li J; Fan L; Li B; Li X; Zhao C; Wu C; Hou L; He Y; Gao G; Chen X; Ren J; Li A; Xu G; Zhou X; Zhou C; Schmid-Bindert G
Int J Cancer; 2014 Dec; 135(12):2962-71. PubMed ID: 24771540
[TBL] [Abstract][Full Text] [Related]
13. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
Al-Saad S; Al-Shibli K; Donnem T; Andersen S; Bremnes RM; Busund LT
J Thorac Oncol; 2010 Oct; 5(10):1536-43. PubMed ID: 20802349
[TBL] [Abstract][Full Text] [Related]
16. TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma.
Pallier K; Cessot A; Côté JF; Just PA; Cazes A; Fabre E; Danel C; Riquet M; Devouassoux-Shisheboran M; Ansieau S; Puisieux A; Laurent-Puig P; Blons H
PLoS One; 2012; 7(1):e29954. PubMed ID: 22272264
[TBL] [Abstract][Full Text] [Related]
17. Slug is associated with poor survival in squamous cell carcinoma of the lung.
Merikallio H; T TT; Pääkkö P; Mäkitaro R; Kaarteenaho R; Lehtonen S; Salo S; Salo T; Harju T; Soini Y
Int J Clin Exp Pathol; 2014; 7(9):5846-54. PubMed ID: 25337226
[TBL] [Abstract][Full Text] [Related]
18. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
19. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
[TBL] [Abstract][Full Text] [Related]
20. Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer.
Wulf MA; Bode B; Zimmermann D; Rufibach K; Weder W; Moch H; Soltermann A; Tischler V
Am J Surg Pathol; 2012 Dec; 36(12):1801-8. PubMed ID: 23154768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
